PetVivo Holdings, Inc. (PETVW)

US — Healthcare Sector
Peers: PETV  IINNW  NLSPW  ZIVOW  GMVDW 

Automate Your Wheel Strategy on PETVW

With Tiblio's Option Bot, you can configure your own wheel strategy including PETVW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PETVW
  • Rev/Share 0.0463
  • Book/Share -0.0337
  • PB -20.7879
  • Debt/Equity -3.4088
  • CurrentRatio 0.4178
  • ROIC -6.0438

 

  • MktCap 16491860.0
  • FreeCF/Share -0.2748
  • PFCF -2.9091
  • PE -1.6735
  • Debt/Assets 0.761
  • DivYield 0
  • ROE -28.0696

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About PetVivo Holdings, Inc. (PETVW)

  • IPO Date 2021-08-11
  • Website http://www.petvivo.com
  • Industry Medical - Devices
  • CEO John Lai
  • Employees 20

PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.